foxo4-dri peptide senolytic 2023 2024

foxo4-dri peptide senolytic 2023 2024 FOX04-DRI Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri peptide senolytic 2023 2024 FOX04-DRI Peptide inhibitors targeting FOXO4-p53 interactions
Brand: clintoncounty708.com
SKU: 42374747564
Price: 29.88 USD
Availability: InStock
Rating: 4.765000000000001 (29 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry

SKU: 42374747564 · From clintoncounty708.com

4.8

USD29.88 USD63.88

Pay in 4 interest-free payments of $7.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Athira Pharma's fosgonimeton (ATH-1017), part of the same HGF/c-Met program, failed the primary endpoint of its Phase 2/3 LIFT-AD Alzheimer's trial in September 2024